部分图表信息呈现对产科决策的影响
1University Department of Obstetrics and Gynaecology, St James' Hospital, Leeds, UK.
Lancet (London, England)
|June 20, 1992
概括
在分娩图表上对分娩数据的视觉呈现显著地影响了产科医生.
科学领域:
- 产科和妇科 产科和妇科
- 医疗决策 - - 医疗决策
- 临床信息学 临床信息学
背景情况:
- 医疗信息的呈现可以影响临床决策.
- 产部图是监测分娩进展的关键工具.
- 部分图表显示的变化可能会影响产科干预.
研究的目的:
- 评估是否改变分娩图的视觉外观会影响产科医生在分娩期间的临床决策.
- 为了研究部分图谱尺度和隐性阶段的纳入对干预率的影响.
主要方法:
- 对16名初级产科医生提出了6个假设的艰难分娩病例.
- 部分图表的外观是多样化的,操纵x-y轴的尺度和包含潜伏阶段.
- 产科医生的管理决策和干预可能性被记录下来.
主要成果:
- 当分娩进展曲线看起来平坦时,医生更容易积极干预.
- 将潜伏阶段纳入部分程序也增加了干预的可能性.
- 部分图的图形表示 (形状,起源) 可能会影响干预率.
结论:
- 部分图的视觉设计在产科干预决策中起着重要作用.
- 部分图表的呈现可能部分解释了医院间剖腹产率的差异.
- 优化部分图形可视化可以标准化劳动力管理,减少不必要的干预.
相关概念视频
Methods of Documentation III: PIE
Problem-intervention-evaluation (PIE) is a systematic approach to documentation used in healthcare settings for clinical decision-making and patient care planning. It is a structured approach to organizing patient data based on problems, interventions, and evaluations. Here's a breakdown of its key features and considerations:
Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Fetal Circulation
Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
Hormonal Regulation of the Menstrual Cycle
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
Hormonal Control of the Ovarian Cycle
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Intrauterine Drug Delivery Systems
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...


